Revel, a unified software platform for hardware test and control, today announced $150 million in Series B funding to accelerate its expansion across aerospace, defense, robotics, and industrial ...
The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing ...
The company behind Claude once promised to build safe and ethical tech. Pete Hegseth is putting that promise to the test.
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
If you'd like to use Linux, but want to have the good old Windows 11 theme, fear not; with the help of KDE Plasma, you can have that very thing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results